TeleCareSpot vs Willow
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Flat-priced compounded semaglutide or tirzepatide with broad state coverage.
- semaglutide
- $299/mo+ membership fee
- tirzepatide
- $399/mo
Before enrolling
The published LegitScript seal ID, #45936855, did not resolve at our last documented check; current certification status remains unconfirmed
Desk Score
Mainstream telehealth GLP-1 access.
- semaglutide
- From $299/molowest dose rung
- tirzepatide
- From $399/molowest dose rung
Before enrolling
The price rises with dose: tirzepatide injections go from $399/mo at the three lowest doses to $549/mo at 17 mg, and semaglutide from $299/mo to $399/mo at 7 mg
Our review of TeleCareSpot gives it 71/100 (C), while our review of Willow gives it 65/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
71/100
C
65/100
C
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | TeleCareSpot | Willow |
|---|---|---|
| Semaglutide | $299/mo+ membership feeFull plan terms$299/mo (all doses, plus a separate fee, compounded) | From $299/molowest dose rungFull plan terms$299/mo (starting dose, compounded injectable or tablet; monthly subscription; injectable is $299/mo for all dosages up to 3.5 mg and $399/mo at 7 mg; tablet $299/mo at all dosages) |
| Tirzepatide | $399/moFull plan terms$399/mo | From $399/molowest dose rungFull plan terms$399/mo (starting dose, compounded injectable or tablet; monthly subscription; injectable is $399/mo at 2.125, 4.25 and 6.375 mg, $499/mo at 8.5 and 11 mg, $524/mo at 13.5 mg and $549/mo at 17 mg; tablet $399/mo at 6 and 10 mg, $459/mo at 20 mg) |
| Coverage | 48 states | Not nationwide (its about page says it serves a limited set of states because of differing telehealth regulations; the list is shown as a graphic we could not read) |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Oral option listed | Oral option listed |
| Best for | Flat-priced compounded semaglutide or tirzepatide with broad state coverage. | Mainstream telehealth GLP-1 access. |
| Desk Score | 71/100C | 65/100C |
The verdict
Desk pick — TeleCareSpotTeleCareSpot has the higher Desk Score, but Willow may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Flat-priced compounded semaglutide or tirzepatide with broad state coverage.
Mainstream telehealth GLP-1 access.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs TeleCareSpot
- CoreAge Rx vs Willow
- Apex MD vs TeleCareSpot
- Apex MD vs Willow
- MEDGm vs TeleCareSpot
- Kova vs Willow
Or see the full comparison hub and the complete ranking.